Literature DB >> 24745926

New Insight into Urate-Related Mechanism of Cardiovascular Damage.

Davide Grassi1, Giovambattista Desideri, Claudio Ferri.   

Abstract

Several experimental and clinical studies reported that hyperuricemia may trigger hypertension, metabolic syndrome, vascular damage and renal disease. Furthermore, a substantial proportion of epidemiological studies are compatible with the hypothesis that hyperuricemia may be an indipendent risk factor for cardiovascular disease as well as for an increased cardiovascular mortality. Xanthine oxidase is a critical source of reactive oxygen species contributing to vascular inflammation and endothelial dysfunction. Although a causal relationship between these conditions has not been clearly clarified, the capacity of uric acid to negatively affect vascular function by pro-oxidant effects and by decreasing nitric oxide bioavailability and consequently induce endothelial dysfunction may explain the association among hyperuricemia, hypertension, metabolic syndrome, and cardiovascular disease, also by a common mechanicistic point of view.

Entities:  

Mesh:

Year:  2014        PMID: 24745926     DOI: 10.2174/1381612820666140417095730

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms.

Authors:  Chiara Barisione; Silvano Garibaldi; Claudio Brunelli; Manrico Balbi; Paolo Spallarossa; Marco Canepa; Pietro Ameri; Francesca Viazzi; Daniela Verzola; Alessandra Lorenzoni; Riccardo Baldassini; Domenico Palombo; Bianca Pane; Giovanni Spinella; Giorgio Ghigliotti
Journal:  Intern Emerg Med       Date:  2015-10-28       Impact factor: 3.397

2.  Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study.

Authors:  Francesco Rozza; Valentina Trimarco; Raffaele Izzo; Davide Grassi; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-09-19

Review 3.  Prevention of rheumatic diseases: strategies, caveats, and future directions.

Authors:  Axel Finckh; Kevin D Deane
Journal:  Rheum Dis Clin North Am       Date:  2014-09-04       Impact factor: 2.670

4.  Association Between the Serum Uric Acid Levels and Lacunar Infarcts in the Elderly.

Authors:  F Crosta; U Occhiuzzi; G Passalacqua; E Occhiuzzi; A Cimini; D Grassi; C Ferri; C Marini; C Borghi; G Desideri
Journal:  J Mol Neurosci       Date:  2018-07-04       Impact factor: 3.444

Review 5.  Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.

Authors:  Takeshi Nishino; Ken Okamoto
Journal:  J Biol Inorg Chem       Date:  2014-12-12       Impact factor: 3.358

6.  The C-terminal peptide plays a role in the formation of an intermediate form during the transition between xanthine dehydrogenase and xanthine oxidase.

Authors:  Tomoko Nishino; Ken Okamoto; Yuko Kawaguchi; Tomohiro Matsumura; Bryan T Eger; Emil F Pai; Takeshi Nishino
Journal:  FEBS J       Date:  2015-04-13       Impact factor: 5.542

7.  Primary Prevention of Cardiovascular Risk in Octogenarians by Risk Factors Control.

Authors:  Pasquale Palmiero; Annapaola Zito; Maria Maiello; Annagrazia Cecere; Anna Vittoria Mattioli; Roberto Pedrinelli; Pietro Scicchitano; Marco Matteo Ciccone
Journal:  Curr Hypertens Rev       Date:  2019

8.  Association between serum vitamin D and uric acid in the eastern Chinese population: a population-based cross-sectional study.

Authors:  Yingchao Chen; Jing Cheng; Yi Chen; Ningjian Wang; Fangzhen Xia; Chi Chen; Bing Han; Yingli Lu
Journal:  BMC Endocr Disord       Date:  2020-06-03       Impact factor: 2.763

9.  Potential causal associations between vitamin D and uric acid: Bidirectional mediation analysis.

Authors:  Ammarin Thakkinstian; Thunyarat Anothaisintawee; Laor Chailurkit; Wipa Ratanachaiwong; Sukit Yamwong; Piyamitr Sritara; Boonsong Ongphiphadhanakul
Journal:  Sci Rep       Date:  2015-09-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.